This questionnaire is designed to measure satisfaction with treatment for macular disease including late-onset macular degeneration.
The Macular Disease Treatment Satisfaction Questionnaire (MacTSQ) was developed in 2006/7 and is based on the Diabetes Treatment Satisfaction Questionnaire (DTSQ) and the Retinopathy Treatment Satisfaction Questionnaire (RetTSQ). The MacTSQ was designed with the help of members of several Macular Disease Society self-help groups, using in-depth interviews. The MacTSQ was revised in 2012 and is available in several languages. The psychometric development was conducted using a dataset from a British clinical trial, the IVAN trial, comparing treatment regimens for an anti-VEGF drug administered by intraocular injection. The scoring algorithm was prepared following psychometric analysis and development.